0001567619-19-001152.txt : 20190115 0001567619-19-001152.hdr.sgml : 20190115 20190115161405 ACCESSION NUMBER: 0001567619-19-001152 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190115 DATE AS OF CHANGE: 20190115 EFFECTIVENESS DATE: 20190115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Erasca, Inc. CENTRAL INDEX KEY: 0001761918 IRS NUMBER: 831217027 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-330625 FILM NUMBER: 19527252 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 465-6511 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001761918 Erasca, Inc. 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 (858) 465-6511 DELAWARE None None Corporation true 2018 Jonathan Lim, M.D. 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Executive Officer Director President and Executive Chairman Gary Yeung, CFA 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Executive Officer Chief Business Officer James A. Bristol, Ph.D. 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Director Alexander W. Casdin 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Director Pratik S. Multani, M.D. 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2018-10-30 false true false 0 45000000 41358237 3641763 false 27 0 0 0 false Erasca, Inc. /s/ Jonathan E. Lim, M.D. Jonathan E. Lim, M.D. President 2019-01-15